Caffeic acid treatment alters the extracellular adenine nucleotide hydrolysis in platelets and lymphocytes of adult rats

Food and Chemical Toxicology

Volumn 56, Issue , 2013, Pages 459-466

  Anwar, Javed ^a   Spanevello, Roselia Maria ^b   Pimentel, Victor Camera ^a   Gutierres, Jessié ^a   Thomé, Gustavo ^a   Cardoso, Andreia ^a   Zanini, Daniela ^a   Martins, Caroline ^a   Palma, Heloisa Einloft ^a   Bagatini, Margarete Dulce ^c   Baldissarelli, Jucimara ^a   Schmatz, Roberta ^a   Leal, Cláudio Alberto Martins ^a   Costa, Pauline da ^a   Morsch, Vera Maria ^a   Schetinger, Maria Rosa Chitolina ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c UNIVERSIDADE FEDERAL DA FRONTEIRA SUL   (Brazil)

Author keywords

Caffeic acid; Ectonucleotidases; Lymphocytes; Platelet aggregation; Platelets

Indexed keywords

5' NUCLEOTIDASE; ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; CAFFEIC ACID; CLOPIDOGREL; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; NUCLEOTIDASE; NUCLEOTIDE PYROPHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; LYMPHOCYTE; MALE; NONHUMAN; NORMAL HUMAN; RAT; THROMBOCYTE AGGREGATION INHIBITION;

ADENINE NUCLEOTIDES; ADENOSINE DEAMINASE; ADENOSINE TRIPHOSPHATASES; ANIMALS; BLOOD PLATELETS; CAFFEIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROLYSIS; LYMPHOCYTES; MALE; PHOSPHORIC DIESTER HYDROLASES; PLATELET AGGREGATION; PYROPHOSPHATASES; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 84876324589     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.02.030     Document Type: Article

References (59)

1. Aldrich M., Blackburn M., Kellems R. The importance of adenosine deaminase for lymphocyte development and function. Biochem. Biophys. Res. 2000, 272:311-335.
2. Anfossi G., Russo I., Massuco P., Mattielo L., Cavalot F., Balbo A., Trovati M. Adenosine increases human platelet levels of 3',5'-cGMP through role in this antiagreggating effect. Thromb. Res. 2002, 105:71-78.
3. Atkinson B., Dwyer K., Enjyoji K., Robson S.C. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets. Blood Cell Mol. Dis. 2006, 36:217-222.
4. Azmi A.S., Bhat S.H., Hadi S.M. Resveratrol-Cu (II) induced DNA breakage in human peripheral lymphocytes: implications for anticancer properties. FEBS Lett. 2005, 579:3131-3135.
5. Azuma K., Eppoushi K., Nakayma M., Ito H., Higasho H., Terao J. Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J. Agric. Food Chem. 2000, 48:5496-5500.
6. Ban J.Y., Cho S.O., Koh S.B., Song K.S., Bae K., Seong Y.H. Protection of amyloid beta protein (25-35)-induced neurotoxicity by methanol extract of Smilacis chinae rhizome in cultured rat cortical neurons. J. Ethnopharmacol. 2006, 106:230-237.
7. Beyer G., Melzig M.F. Effects of selected flavonoids and caffeic acid derivatives on hypoxanthine-xanthine oxidaseinduced toxicity in cultivated human cells. Planta Med. 2003, 69:1125-1129.
8. Bhat S.H., Azmi A.S., Hadi S.M. Prooxidant DNA breakage induced by caffeic acid in human peripheral lymphocytes: involvement of endogenous copper and a putative mechanism for anticancer properties. Toxicol. Appl. Pharmacol. 2007, 218:249-255.
9. Birk A.V., Broekman J., Gladek E.M., Robertson H.D., Drosopoulos J.H.F., Marcus A.J., Szeto H. Role of a novel soluble nucleotide phosphohydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology. J. Lab. Clin. Med. 2002, 139:116-124.
10. Bonita J.S., Mandarano M., Shuta D., Vinson J. Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies. Pharmacol. Res. 2007, 55:187-198.
11. Born G.V.R., Cross M.J. The aggregation of blood platelets. J. Physiol. 1963, 95:168-178.
12. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein - dye binding. Anal. Biochem. 1976, 72:248-254.
13. Burnstock G. Introduction: P2 receptors. Curr. Top. Med. Chem. 2004, 4:793-803.
14. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1g. Scand. J. Clin. Lab. Invest. 1968, 97:77-89.
15. 2+-stimulated ATPase activity. Anal. Biochem. 1986, 157:375-380.
16. Chan J.H., Ho C.T. Antioxidant activities of caffeic acid and its related hydroxy cinnamic acid compounds. J. Agric. Food Chem. 1997, 45:2374-2378.
17. Chung T.W., Moon S.K., Chang Y.C., Ko J.H., Lee Y.C., Cho G., Kim S.H., Kim J.G., Kim C.H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 2004, 18:1670-1681.
18. Clifford M.N. Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J. Sci. Food Agric. 1999, 79:362-372.
19. Colgan S.P., Eltzschig H.K., Eckle T., Thompson L.F. Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal. 2006, 2:351-360.
20. +-ATPase and acetylcholinesterase activities by subchronic treatment with casearia sylvestris. Phytomedicine 2006, 13:509-514.
21. Dombrowski K.E., Ke Y., Brewer K.A., Kapp J.A. Ecto-ATPase: an activation marker necessary for effector cell function. Immunol. Rev. 1998, 161:111-118.
22. Dombrowski K.E., Ke Y., Thompson L.F., Kapp J.A. Antigen recognition by CTL is dependent upon ectoATPase activity. J. Immunol. 1995, 154:6227-6237.
23. Dorsam R.T., Kunapuli S.P. Central role of the P2Y12 receptor in platelet activation. J. Clin. Invest. 2004, 113:340-345.
24. Dwyer K., Deaglio S., Gao W., Friedman D., Strom T., Robson S. CD39 and control of cellular immune responses. Purinergic Signal. 2007, 3:171-180.
25. Franco R., Casadó V., Ciruela F., Saura C., Mallol J., Canela E.I., Lluis C. Cell surface adenosine deaminase: much more than an ectoenzyme. Prog. Neurobiol. 1997, 52:283-292.
26. Fürstenau C.R., Trentin D.S., Barreto-Chaves M.L.M., Sarkis J.J.F. Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties. Platelets 2006, 17:84-91.
27. Gachet C. ADP receptors of platelets and their inhibition. Thromb. Haemost. 2001, 86:222-232.
28. Gessi S., Varani K., Merighi S., Fogli E., Sacchetto V., Benini A., Leung E., Mac-Lennan S., Borea P.A. Adenosine and lymphocyte regulation. Purinergic Signal. 2007, 3:109-116.
29. Giusti G. Adenosine deaminase. Methods of Enzymatic Analysis 1974, 1092-1099. Acad Press, New York. 3rd ed. H.U. Bergmeyer (Ed.).
30. Gulcin I. Antioxidant activity of caffeic acid. Toxicology 2006, 217:213-220.
31. Hechler B., Cattaneo M., Gachet C. The P2 receptors in platelet function. Semin. Thromb. Haemost. 2005, 31:150-161.
32. Hershfield M.S. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur. J. immunol. 2005, 35:25-30.
33. Hirose M., Takesada Y., Tanaka H., Tamano S., Kato T., Shirai T. Carcinogenicity of antioxidants butylated hydroxyanisole, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination and modulation of their effects in a rat medium-term multiorgan carcinogenesis model. Carcinogenesis 1998, 19:207-212.
34. Hourani S.M. Purinoceptors and platelet aggregation. Auton. Pharmacol. 1996, 16:349-352.
35. Hubbard G.P., Wolffram S., Lovegrove J.A., Gibbins J.M. The role of polyphenolic compounds in the diet as inhibitors of platelet function. Proc. Nutr. Soc. 2003, 62:469-478.
36. Jaques J.A.S., Rezer J.F.P., Ruchel J.B., Becker L.V., da Rosaa C.S., Souza V.C.G., Luz S.C.A., Gutierres J.M., Goncalves J.F., Morsch V.M., Schetinger M.R.C., Leal D.B.R. Lung and blood lymphocytes NTPDase and acetylcholinesterase activity in cigarette smoke-exposed rats treated with curcumin. Biomed. Prevent. Nutr. 2011, 1:109-115.
37. Leal D.B.R., Streher C.A., Bertoncheli C., Carli L.F.D., Leal C.A.M., da Silva J.E.P., Morsch V.M., Schetinger M.R.C. HIV infection is associated with increased NTPDase activity correlates with CD39-positive lymphocytes. Biochim. Biophys. Acta 2005, 1746:129-134.
38. Leal D.B.R., Streher C.A., Neu T.N., Bittencourt F.P., Leal C.A.M., Silva J.E.P., Morsch V.M., Schetinger M.R.C. Characterization of NTPDase (NTPDase 1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Biochim. Biophys. Acta 2005, 1721:9-15.
39. Lunkes G.I., Lunkes D.S., Morsch V.M., Mazzanti C.M., Morsch A.L., Miron V.R., Schetinger M.R. NTPDase and 5-nucleotidase in rats alloxan - induced diabetes. Diab. Res. Clin. Pract. 2004, 65:1-6.
40. Moheimani, F., Jackon, D., in press. P2Y12 receptor: platelet thrombus formation and medical interventions. Int. J. Hematol.
41. 14C] Caffeic Acid in Rats. J. Agric. Food Chem. 2012, 60:5205-5214.
42. Ostertag L.M., O'Kennedy N., Horgan G.W., Kroon P.A., Duthie G.G., de Roos B. In vitro anti-platelet effects of simple plant-derived phenolic compounds are only found at high, non-physiological concentrations. Mol. Nutr. Food Res. 2011, 55:1624-1636.
43. Olthof M., Holmann P., Katan M. Chlorogenic acid and caffeic acid are absorbed in humans. J. Nutr. 2001, 131:66-71.
44. Pereillo J.M., Maftouh M., Andrieu A., Uzabiaga M.F., Fedeli O., Savi P., Pascal M., Herbert J.M., Maffrand J.P., Picard C. Structure and stereochemistry of the active metabolite from clopidogrel. Drug Metab. Dispos. 2002, 30:1288-1295.
45. Psotova J., Lasovsky J., Vicor J. Metal chelating properties, electrochemical scavenging and cytoprotective activities of six natural phenolics. Biomed. Pap. 2003, 147:147-153.
46. Pulte E., Broekman M., Olson K., Drosopoulos J., Kizer J., Islam N., Marcus A. CD39/NTPDase - 1 activity and expression in normal leucocytes. Thromb. Res. 2007, 121:309-317.
47. 12 in platelet adhesion and thrombus formation in flowing blood. Arterioscler. Thromb. Vasc. Biol. 2002, 22:686-691.
48. Robson S., Sévigny J., Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal. 2006, 2:409-430.
49. Savi P., Zachayus J.L., Delesque-Touchard N., Labouret C., Herve C., Uzabiaga M.F., Pereillo J.M., Culouscou J.M., Bono F., Ferrara P., Herbert J.M. The active metabolite of clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. PNAS 2006, 103:11069-11074.
50. Schmatz R., Schetinger M.R.C., Spanevello R.M., Mazzanti C.M., Stefanello N., Maldonado P.A., Gutierres J., Corrêa M.C., Girotto E., Moretto M.B., Morsch V.M. Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats. Life Sci. 2009, 84:345-350.
51. Soslau G., Youngprapakorn D. A possible dual physiological role of extracellular ATP in modulation of platelet aggregation. Biochim. Biophys. Acta 1997, 1355:131-140.
52. Spanevello R., Mazzanti C.M., Schmatz R., Bagatini M., Stefanello N., Correa M., Kaizer R., Maldonado P., Mazzanti A., Graca D.L., Martins T.B., Danesi C., Morsch V.M., Schetinger M.R.C. Effect of vitamin E on ectonucleotidase activities in synaptosomes and platelets and parameters of oxidative stress in rats experimentally demyelinated. Brain Res. Bull. 2009, 80:45-51.
53. Strater N. Ecto-5-nucleotidase: structure function relationships. Purinergic Signal. 2006, 2:343-350.
54. Tanaka T., Kojima T., Kawamori T., Wang A., Suzui M., Okamoto K., Mori H. Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis 1993, 14:1321-1325.
55. Thomé G.R., Oliveira L.S., Schetinger M.R.C., Morsch V.M., Spanevello R.M., Fiorenza A.M., Seres J., Baldissarelli J., Stefanello N., Pereira M.E., Calgaroto N.S., Pimentel V.C., Leal D.B.R., Souza V.C.G., Jaques J.A.S., Leal C.A.M., Cruz R.C., Thiesen F.V., Mazzanti C.M. Nicotine alters the ectonucleotidases activities in lymphocytes: In vitro and in vivo studies. Biomed. Pharmacother. 2012, 66:206-212.
56. 2+ induced low density lipoprotein oxidation. FEBS Lett. 1997, 405:186-190.
57. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 2008, 1783:673-694.
58. Zimmermann H., Braun N., Kegel B., Heine P. New insights into molecular structure and function of ectonucleotidases in the nervous system. Neurochem. Int. 1998, 3:421-425.
59. Zimmermann H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Develop. Res. 2001, 52:44-56.